← FDA DRUG APPROVALS

FDA ANDA · ANDA210809

CLOBETASOL PROPIONATE

Sponsor: GLENMARK PHARMS LTD

APPLICATION
ANDA210809
TYPE
ANDA
ORIGINAL APPROVAL
2019-02-15
LATEST ACTION
2023-11-29
ROUTE
TOPICAL
DOSAGE FORM
AEROSOL, FOAM
MARKETING STATUS
Prescription

Products

CLOBETASOL PROPIONATEPrescription
CLOBETASOL PROPIONATE 0.05% · AEROSOL, FOAM · TOPICAL

Approval history

2023-11-29Labeling · Supplement 1 · standardAP
2023-11-29Labeling · Supplement 4 · standardAP
2023-11-29Labeling · Supplement 2 · standardAP
2019-02-15UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →